Atlas Venture Opportunity Fund II, L.P.

Insider Reports History

Entity
Company
Location
300 Technology Square, 8 Th Floor, Cambridge, MA
Signature
Atlas Venture Opportunity Fund II, L.P., By: Atlas Venture Associates Opportunity II, L.P., its general partner, By: Atlas Venture Associates Opportunity II, LLC, its general partner, By: /s/ Ommer Chohan, Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Atlas Venture Opportunity Fund II, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Dyne Therapeutics, Inc. 10%+ Owner Common Stock 1.61M $28.2M $17.50 Dec 12, 2022 Indirect
Dyne Therapeutics, Inc. 10%+ Owner Common Stock 935K $16.4M $17.50 Dec 12, 2022 Direct
Disc Medicine, Inc. 10%+ Owner Common Stock 218K $14.8M $67.65 Dec 29, 2022 Direct
Day One Biopharmaceuticals, Inc. 10%+ Owner Common Stock 991K $11.6M $11.69 Jun 17, 2022 Indirect
Korro Bio, Inc. 10%+ Owner Common Stock 195K $10.9M $56.00 Apr 22, 2024 Direct
Day One Biopharmaceuticals, Inc. 10%+ Owner Common Stock 767K $8.96M $11.69 Jun 17, 2022 Direct

Insider Reports Filed by Atlas Venture Opportunity Fund II, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KRRO Korro Bio, Inc. Apr 22, 2024 1 $1M 4 Apr 23, 2024 10%+ Owner
FREQ Korro Bio, Inc. Nov 3, 2023 0 $0 3 Nov 7, 2023 10%+ Owner
IRON Disc Medicine, Inc. Dec 29, 2022 0 $0 3 Jan 3, 2023 10%+ Owner
DYN Dyne Therapeutics, Inc. Dec 12, 2022 1 $10M 4 Dec 14, 2022 10%+ Owner
DAWN Day One Biopharmaceuticals, Inc. Jun 17, 2022 1 $11.5M 4 Jun 22, 2022 10%+ Owner